CEFUROXIMA ATB 500mg tablets medication leaflet

J01DC02 cefuroxime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Second-generation cephalosporins

Cefuroxime is a second-generation cephalosporin antibiotic used to treat moderate bacterial infections. It is indicated for upper respiratory tract infections (such as sinusitis, tonsillitis, or pharyngitis), lower respiratory tract infections (bronchitis, pneumonia), urinary tract infections, otitis media, skin and soft tissue infections, as well as some bone and joint infections.

Cefuroxime works by inhibiting bacterial cell wall synthesis, killing the bacteria responsible for the infection. It is available in tablet, oral suspension, or injectable solution form.

Side effects may include nausea, diarrhea, abdominal pain, skin rashes, or allergic reactions. In rare cases, it can cause pseudomembranous colitis or severe hypersensitivity reactions. It is contraindicated in patients with allergies to cephalosporins or penicillins.

General data about CEFUROXIMA ATB 500mg

Substance: cefuroxime

Date of last drug list: 01-06-2025

Commercial code: W69774003

Concentration: 500mg

Pharmaceutical form: tablets

Quantity: 10

Product type: generic

Price: 23.89 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: APL SWIFT SERVICES (MALTA) LIMITED - MALTA

Holder: ANTIBIOTICE S.A. - ROMANIA

Number: 13428/2020/03

Shelf life: 3 years

Concentrations available for cefuroxime

1.5g, 125mg, 125mg/5ml, 1500mg, 250mg, 250mg/5ml, 500mg, 50mg, 750mg

Other substances similar to cefuroxime

Compensation lists for CEFUROXIMA ATB 500mg ANTIBIOTICE

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

23.89 RON

21.50 RON

2.39 RON